Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single Percussive Ventilation Breath-hold Imaging and Delivery in Lung Tumor Stereotactic Ablative Radiation Therapy: Initial Observations From a Prospective Clinical Trial.

International journal of radiation oncology, biology, physics·2026
Same author

Margin positivity is not associated with the extent of resection for non-small cell lung cancer.

Surgery·2026
Same author

FLASH reduces radiation-induced oral mucositis in a mouse model of Fanconi anemia.

bioRxiv : the preprint server for biology·2026
Same author

Noninvasive Reversible Software-Based Electron FLASH Irradiation Configuration of a Linear Accelerator in Clinical Use.

International journal of radiation oncology, biology, physics·2026
Same author

Applying a portable pocket handheld ultrasound scanner to monitor tumor volume in preclinical studies.

Medical physics·2026
Same author

Addressing respiratory gating latency for accurate pulse delivery in preclinical electron FLASH irradiation on a clinical linear accelerator.

ArXiv·2026
Same journal

Measuring Equitable Care Delivery: Insights From the Health Equity Report Card (HERC) Pilot in Academic Cancer Centers.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

A Virtual Reality Psychosocial Intervention for Patients Undergoing Bone Marrow Transplantation (BMT-VR): Pilot Randomized Clinical Trial.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Nationwide Trends in Colorectal Cancer Screening by the End of the COVID-19 Pandemic: Racial/Ethnic Differences and Opportunities.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Evaluation of the Impact of Adjuvant Immunotherapy in Merkel Cell Carcinoma.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Payers' Views on Insurance Coverage for Confirmatory Diagnostics After a Noncovered Multicancer Early Detection (MCED) Test.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Surrogacy of Intermediate Clinical Endpoints for Overall Survival in Patients With Localized Muscle-Invasive Bladder Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
See all related articles

Related Experiment Video

Updated: May 10, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Non-small cell lung cancer, version 2.2013.

David S Ettinger1, Wallace Akerley, Hossein Borghaei

  • 1Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, USA.

Journal of the National Comprehensive Cancer Network : JNCCN
|June 8, 2013
PubMed
Summary
This summary is machine-generated.

NCCN Guidelines Insights highlight major updates for diagnosing non-small cell lung cancer. These insights detail recent changes to the clinical practice guidelines for lung cancer evaluation.

More Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Related Experiment Videos

Last Updated: May 10, 2026

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer
07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

Area of Science:

  • Oncology
  • Pulmonology
  • Medical Diagnostics

Background:

  • Lung cancer diagnosis requires timely and accurate evaluation.
  • The National Comprehensive Cancer Network (NCCN) provides evidence-based guidelines for cancer care.
  • Previous NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) were updated in 2013.

Purpose of the Study:

  • To summarize key updates in the diagnostic evaluation of suspected lung cancer.
  • To provide detailed insights into the revised NCCN Clinical Practice Guidelines for Oncology.
  • To focus on the major changes relevant to non-small cell lung cancer diagnosis.

Main Methods:

  • Review of the updated NCCN Clinical Practice Guidelines for Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer.
  • Analysis of significant changes in diagnostic evaluation protocols.
  • Focus on the 2013 guideline updates and their implications.

Main Results:

  • Significant updates have been made to the diagnostic pathways for suspected lung cancer.
  • The revised guidelines offer more detailed approaches to evaluating non-small cell lung cancer.
  • Key changes impact the initial workup and diagnostic procedures.

Conclusions:

  • Adherence to updated NCCN Guidelines is crucial for optimal lung cancer diagnosis.
  • These insights facilitate understanding of the latest recommendations for non-small cell lung cancer evaluation.
  • The updated guidelines aim to improve diagnostic accuracy and patient outcomes.